United States Fluorescent In Situ Hybridization (FISH) Probe Market Research 2024-2029 – Increasing Application in Genetic Research Fuels Growth, Focus on Personalized Medicine Boosts Demand

Dublin, Jan. 08, 2025 (GLOBE NEWSWIRE) — The “United States Fluorescent In Situ Hybridization Probe Market, By Region, Competition Forecast & Opportunities, 2019-2029F” report has been added to ResearchAndMarkets.com’s offering.

The United States Fluorescent In Situ Hybridization Probe Market was valued at USD 320.02 Million in 2023, and is expected to reach USD 491.37 Million by 2029, rising at a CAGR of 7.58%

The United States Fluorescent In Situ Hybridization (FISH) Probe Market is a rapidly evolving sector within the life sciences and diagnostics industry. FISH employs fluorescently labeled probes to target specific genetic sequences in cells, with applications ranging from genetic research to clinical diagnostics. Factors driving market growth include technological advancements, rising rates of genetic disorders and cancer, and the growing interest in personalized medicine. Both developed and emerging economies have seen significant expansion in the FISH Probe market in recent years.

The growth of the United States Fluorescent In Situ Hybridization (FISH) Probe market is significantly fueled by the increasing demand for molecular diagnostics. Molecular diagnostics involve analyzing genetic material like DNA and RNA to diagnose diseases, assess genetic predispositions, and track treatment responses accurately. FISH Probes, a key component of molecular diagnostics, provide exceptional precision in disease detection by identifying specific genetic abnormalities such as chromosomal rearrangements and gene amplifications in patient samples. This precision is particularly vital in diagnosing cancer, where identifying precise genetic markers is crucial for determining the most effective treatment strategies.

The growth of the United States Fluorescent In Situ Hybridization (FISH) Probe market is significantly driven by its expanding applications in research. FISH, a molecular biology technique utilizing fluorescently labeled DNA or RNA probes, offers versatility in targeting specific genetic sequences within cells, making it indispensable for various research endeavors. Genomics, focusing on an organism’s complete genetic makeup, relies on FISH Probes to map specific genes or sequences on chromosomes, facilitating studies on gene function, regulation, and diversity, especially in genetic diseases and evolutionary biology.

The expansion of personalized medicine drives the growth of the United States Fluorescent In Situ Hybridization (FISH) Probe market. Personalized medicine tailors treatment to individual patients based on genetic makeup and lifestyle. FISH Probes are vital for this approach, detecting specific genetic markers guiding treatment decisions. They accurately identify genetic alterations crucial in disease progression, such as gene amplifications in oncology.

Segmental Insights

Technology Insights

Based on technology, the fish flow segment emerged as the dominant player in the United States market for Fluorescent In Situ Hybridization Probe in 2023. This is due to the growing need for genomic profiling in healthcare settings is elevating the significance of Flow Fluorescent In Situ Hybridization (Flow FISH) testing within the market. Flow FISH offers the advantage of automating the screening of over 10,000 cells in just 10 minutes. This not only improves testing efficiency and standardization but also achieves significantly greater repeatability compared to traditional manual FISH testing, analyzing 20 to 100 times more cells.

Flow FISH enables detailed analysis of individual cells at a genetic level while simultaneously capturing other essential cellular characteristics. This is particularly critical in fields such as cancer research and immunology, where the need for comprehensive cellular analysis is paramount. The rising prevalence of chromosomal disorders further underscores the demand for this technology. Flow FISH is increasingly preferred for diagnosing conditions like Dyskeratosis congenita, the first inheritable disorder linked to impaired telomere maintenance. While Dyskeratosis congenita is rare, its occurrence is notably higher in patients with bone marrow failure. These factors are anticipated to fuel the growth of this segment.

Type Insight

Based on type, the DNA segment emerged as the dominant player in the United States market for Fluorescent In Situ Hybridization Probe in 2023. This is because the DNA FISH Probes are essential in cytogenetics for detecting chromosomal abnormalities crucial in diagnosing genetic disorders and cancers. In oncology, they identify gene alterations guiding treatment decisions. This drives market growth.

In genomics research, they map DNA sequences, study gene expression, and aid drug development. The rise of precision medicine, tailoring treatments to genetic profiles, boosts demand for DNA FISH Probes. They also diagnose infectious diseases by identifying pathogen DNA. The ongoing need for precise diagnostics supports this segment’s dominance, likely fueling its growth.

Regional Insights

Northeast emerged as the dominant player in the United States Fluorescent In Situ Hybridization Probe market in 2023, holding the largest market share in terms of value. The Northeast region’s concentration of top healthcare institutions and chronic disease prevalence drives FISH probe demand. New York leads due to institutions like Mount Sinai Hospital. The South region, with a growing population and chronic disease incidence, offers rapid market growth. Florida leads in the South due to its large population and major healthcare institutions like the Mayo Clinic. High per capita income supports healthcare spending in both regions.

Key Attributes:

Competitive Landscape

Detailed analysis of the major companies present in the United States Fluorescent In Situ Hybridization Probe Market.

• Thermo Fisher Scientific Inc.
• Perkinelmer Inc.
• Horizon Diagnostics Plc
• Agilent Technologies, Inc.
• Abnova Corporation
• Genemed Biotechnologies, Inc.
• Oxford Gene Technology IP Limited
• Biocare Medical, LLC.
• QIAGEN N.V.
• GSP Research Institute, Inc.

Key Topics Covered:

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations

2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. United States Fluorescent In Situ Hybridization Probe Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Technology (Flow Fish, Q Fish, Other Fish)
5.2.2. By Type (DNA, RNA)
5.2.3. By Application (Cancer Research, Genetic Disorder, Others)
5.2.4. By End-User (Research, Clinical, Companion Diagnostics)
5.2.5. By Region
5.2.6. By Company (2023)
5.3. Market Map
5.3.1. By Technology
5.3.2. By Type
5.3.3. By Application
5.3.4. By End-User
5.3.5. By Region

6. Northeast United States Fluorescent In Situ Hybridization Probe Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Technology
6.2.2. By Type
6.2.3. By Application
6.2.4. By End-User

7. West Fluorescent In Situ Hybridization Probe Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Technology
7.2.2. By Type
7.2.3. By Application
7.2.4. By End-User

8. South Fluorescent In Situ Hybridization Probe Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Technology
8.2.2. By Type
8.2.3. By Application
8.2.4. By End-User

9. Midwest Fluorescent In Situ Hybridization Probe Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Technology
9.2.2. By Type
9.2.3. By Application
9.2.4. By End-User

10. Market Dynamics
10.1. Drivers
10.2. Challenges

11. Market Trends & Developments
11.1. Recent Developments
11.2. Product Launches
11.3. Mergers & Acquisitions

12. United States Fluorescent In Situ Hybridization Probe Market: SWOT Analysis

13. Competitive Landscape
13.1. Business Overview
13.2. Company Snapshot
13.3. Products & Services
13.4. Financials (In case of listed)
13.5. Recent Development
13.6. SWOT Analysis

For more information about this report visit https://www.researchandmarkets.com/r/stpt8u

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

• U.S. Fluorescent In Situ Hybridization Probe Market